Tobramycin Range

Tobramycin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified PCD pharma franchise company offering a Tobramycin range of 15 formulations across eye drops, eye ointment, injection and rota cap forms — one of the broadest single-molecule ranges we carry. All products are manufactured at approved facilities and offered with district-level monopoly rights.

What is Tobramycin?

Tobramycin is a bactericidal aminoglycoside antibiotic. It binds irreversibly to the bacterial 30S ribosomal subunit, causing misreading of messenger RNA and the production of non-functional proteins, which kills the organism. It is particularly valued for its activity against Pseudomonas aeruginosa and other aerobic Gram-negative bacilli. Topically it treats bacterial eye infections; systemically it is reserved for serious Gram-negative infections; and in inhaled form it is used against chronic Pseudomonas colonisation of the airways. It is prescription-only in all forms. Compound and pharmacology data are available on PubChem.

Tobramycin Formulations Available with Cafoli Lifecare

The Tobramycin portfolio comprises 15 formulations across eye drops, eye ointment, injection and rota cap presentations, including combination products used in ophthalmic practice. Composition, packing and net rates are shared on enquiry.

Therapeutic Applications of Tobramycin

• Bacterial conjunctivitis, blepharitis and keratitis (eye drops and eye ointment)
• Post-operative infection prophylaxis in ophthalmic surgery, at the surgeon's discretion
• Serious Gram-negative infections including septicaemia, complicated urinary tract infection and hospital-acquired pneumonia (injection)
• Chronic Pseudomonas aeruginosa airway colonisation in bronchiectasis and cystic fibrosis (inhaled form)

Prescribers therefore span ophthalmologists, intensivists and critical care physicians, surgeons, infectious disease specialists and pulmonologists. Systemic use requires renal function monitoring because aminoglycosides carry nephrotoxic and ototoxic potential.

Why Tobramycin is a High-Potential Molecule for Distributors

Most molecules give a distributor one prescriber and one call cycle. Tobramycin gives three. The eye drops and ointment move through ophthalmologists and eye hospitals at retail volume; the injection moves through hospital pharmacies and ICUs at high value per vial; the inhaled presentation reaches pulmonologists managing chronic Pseudomonas. That means a single molecule can be worked into an ophthalmic range, a critical care range and a respiratory range from the same stock list — unusual leverage for a partner building coverage across specialties. Underpinning all of it is the reliability of tobramycin's anti-Pseudomonas activity at a time when Gram-negative resistance is narrowing the alternatives, which keeps the molecule firmly in Indian hospital formularies rather than drifting out of use.

Why Choose Cafoli Lifecare for Your Tobramycin Franchise

• Monopoly rights — one partner per district, territory protected
• WHO-GMP certified manufacturing and DCGI-approved formulations
• Promotional inputs — visual aids, doctor sample packs, literature, reminder gifts and MR bags
• 1000+ franchise partners across India
• On-time despatch, transparent net rates and dedicated order support

References

1. PubChem — Tobramycin compound record, National Library of Medicine
2. WHO Model List of Essential Medicines
3. PubMed — clinical literature on tobramycin